Literature DB >> 1080790

Localization of aggregated cell surface antigens of target cells bound to cytotoxic T lymphocytes.

G Berke, Z V Fishelson.   

Abstract

The redistribution of aggregated cell surface antigens of target cells bound to cytotoxic T lymphocytes was investigated. It was found that cap formation induced by antibody always occurred toward the site of binding. It is suggested that the polar localization of capped target cell surface determinants is a consequence of cytotoxic T-lymphocyte target cell interaction.

Mesh:

Substances:

Year:  1975        PMID: 1080790      PMCID: PMC2189953          DOI: 10.1084/jem.142.4.1011

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

Review 1.  The membrane actions of anesthetics and tranquilizers.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1972-12       Impact factor: 25.468

2.  Binding of thymus- and bone marrow-derived lymphoid cells to antigen-derivatized fibers.

Authors:  U Rutishauser; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

3.  Evaluation of the effects of cytochalasin B on lymphocyte-mediated cytolysis.

Authors:  R D Stulting; G Berke; K Hiemstra
Journal:  Transplantation       Date:  1973-12       Impact factor: 4.939

4.  Studies on the mechanism of lymphocyte-mediated cytolysis. 3. The role of microfilaments and microtubules.

Authors:  M Plaut; L M Lichtenstein; C S Henney
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

5.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

Review 6.  Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity.

Authors:  G Berke; D B Amos
Journal:  Transplant Rev       Date:  1973

7.  Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity.

Authors:  B D Brondz; I K Egorov; G I Drizlikh
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

8.  Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorption.

Authors:  R D Stulting; G Berke
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

9.  Cellular immunoabsorbents in transplantation immunity. Specific in vitro deletion and recovery of mouse lymphoid cells sensitized against allogeneic tumors.

Authors:  G Berke; R H Levey
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  Ligand-induced movement of lymphocyte membrane macromolecules. V. Capping, cell movement, and microtubular function in normal and lectin-treated lymphocytes.

Authors:  E R Unanue; M J Karnovsky
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  4 in total

1.  The receptor specificity of alloreactive T cells. Distinction between stimulator K, I, and D region products and degeneracy of third-party H-2 recognition by low-affinity T cells.

Authors:  Z A Nagy; B E Elliott
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

2.  Dissociation of H-2 recognition by antibody and cytotoxic T cells of a cloned murine leukemia cell line.

Authors:  J L Portis; F J McAtee
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

3.  Binding of HLA antigen-containing liposomes to bacteria.

Authors:  L Klareskog; G Banck; A Forsgren; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

4.  Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.

Authors:  Eilon Woolf; Cuiying Xiao; Ofer Fainaru; Joseph Lotem; Dalia Rosen; Varda Negreanu; Yael Bernstein; Dalia Goldenberg; Ori Brenner; Gideon Berke; Ditsa Levanon; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-09       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.